Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer
- PMID: 22726230
- PMCID: PMC3460750
- DOI: 10.1186/1472-6874-12-17
Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer
Abstract
Background: Breast cancer today has many established risk factors, both genetic and environmental, but these risk factors by themselves explain only part of the total cancer incidence. We have investigated potential interactions between certain known genetic and phenotypic risk factors, specifically nine single nucleotide polymorphisms (SNPs) and height, body mass index (BMI) and hormone replacement therapy (HRT).
Methods: We analyzed samples from three different study populations: two prospectively followed Swedish cohorts and one Icelandic case-control study. Totally 2884 invasive breast cancer cases and 4508 controls were analysed in the study. Genotypes were determined using Mass spectrometry-Maldi-TOF and phenotypic variables were derived from measurements and/or questionnaires. Odds Ratios and 95% confidence intervals were calculated using unconditional logistic regression with the inclusion of an interaction term in the logistic regression model.
Results: One SNP (rs851987 in ESR1) tended to interact with height, with an increasingly protective effect of the major allele in taller women (p = 0.007) and rs13281615 (on 8q24) tended to confer risk only in non users of HRT (p-for interaction = 0.03). There were no significant interactions after correction for multiple testing.
Conclusions: We conclude that much larger sample sets would be necessary to demonstrate interactions between low-risk genetic polymorphisms and the phenotypic variables height, BMI and HRT on the risk for breast cancer. However the present hypothesis-generating study has identified tendencies that would be of interest to evaluate for gene-environment interactions in independent materials.
Figures
Similar articles
-
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26. J Natl Cancer Inst. 2011. PMID: 21791674 Free PMC article.
-
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.Lancet. 2010 Jun 19;375(9732):2143-51. doi: 10.1016/S0140-6736(10)60636-8. Epub 2010 Jun 3. Lancet. 2010. PMID: 20605201 Free PMC article.
-
Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.Oncol Rep. 2011 Aug;26(2):479-85. doi: 10.3892/or.2011.1298. Epub 2011 May 10. Oncol Rep. 2011. PMID: 21567099
-
Gene-environment interactions for breast cancer risk among Chinese women: a report from the Shanghai Breast Cancer Genetics Study.Am J Epidemiol. 2013 Jan 15;177(2):161-70. doi: 10.1093/aje/kws238. Epub 2012 Dec 6. Am J Epidemiol. 2013. PMID: 23221726 Free PMC article.
-
Gene-environment interaction and risk of breast cancer.Br J Cancer. 2016 Jan 19;114(2):125-33. doi: 10.1038/bjc.2015.439. Epub 2016 Jan 12. Br J Cancer. 2016. PMID: 26757262 Free PMC article. Review.
Cited by
-
Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.Epidemiol Rev. 2014;36(1):114-36. doi: 10.1093/epirev/mxt010. Epidemiol Rev. 2014. PMID: 24375928 Free PMC article. Review.
-
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.J Natl Cancer Inst. 2015 Nov 5;108(2):djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. J Natl Cancer Inst. 2015. PMID: 26546117 Free PMC article. Review.
-
Interaction between common breast cancer susceptibility variants, genetic ancestry, and nongenetic risk factors in Hispanic women.Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1731-8. doi: 10.1158/1055-9965.EPI-15-0392. Epub 2015 Sep 12. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26364163 Free PMC article.
-
Menopausal hormone therapy and breast cancer mortality: clinical implications.Ther Adv Drug Saf. 2015 Apr;6(2):45-56. doi: 10.1177/2042098614568300. Ther Adv Drug Saf. 2015. PMID: 25922653 Free PMC article. Review.
-
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women.Sci Rep. 2022 Apr 13;12(1):6199. doi: 10.1038/s41598-022-10121-2. Sci Rep. 2022. PMID: 35418701 Free PMC article.
References
-
- Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A. et al.A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007;39:870–874. doi: 10.1038/ng2075. - DOI - PMC - PubMed
-
- Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, Masson G, Jakobsdottir M, Thorlacius S, Helgason A. et al.Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2007;39:865–869. doi: 10.1038/ng2064. - DOI - PubMed
-
- Reeves GK, Travis RC, Green J, Bull D, Tipper S, Baker K, Beral V, Peto R, Bell J, Zelenika D, Lathrop M. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA. 2010;304:426–434. doi: 10.1001/jama.2010.1042. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous